{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:48:26Z","timestamp":1790153306033,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["103-2314-B-002-057-MY3"],"award-info":[{"award-number":["103-2314-B-002-057-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12035-017-0763-4","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T16:56:20Z","timestamp":1505148980000},"page":"5299-5309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice"],"prefix":"10.1007","volume":"55","author":[{"given":"Ni-Chung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin J.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nien-Chu","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kai","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-5728","authenticated-orcid":false,"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"763_CR1","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited disease, vol III","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser A (2001) Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease, vol III, 8th edn. McGraw-Hill, New York, pp. 3389\u20133420","edition":"8"},{"issue":"9227","key":"763_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","volume":"356","author":"H Hout Van den","year":"2000","unstructured":"Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT (2000) Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356(9227):397\u2013398","journal-title":"Lancet"},{"issue":"16","key":"763_CR3","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","volume":"96","author":"A Amalfitano","year":"1999","unstructured":"Amalfitano A, McVie-Wylie AJ, Hu H, Dawson TL, Raben N, Plotz P, Chen YT (1999) Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A 96(16):8861\u20138866","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"763_CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"P Kishnani","year":"2007","unstructured":"Kishnani P, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J et al (2007) Recombinant human acid {alpha}-glucosidase. Major clinical benefits in infantile-onset Pompe disease. Neurology 68(2):99\u2013109","journal-title":"Neurology"},{"issue":"3","key":"763_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","volume":"66","author":"PS Kishnani","year":"2009","unstructured":"Kishnani PS, Corzo D, Leslie ND, Gruskin D, Van der Ploeg A, Clancy JP, Parini R, Morin G et al (2009) Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. Pediatr Res 66(3):329\u2013335","journal-title":"Pediatr Res"},{"issue":"5","key":"763_CR6","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JM Hout Van den","year":"2004","unstructured":"Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A et al (2004) Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113(5):e448\u2013e457","journal-title":"Pediatrics"},{"issue":"3","key":"763_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","volume":"11","author":"M Nicolino","year":"2009","unstructured":"Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, Arnold GL, Pivnick EK et al (2009) Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med 11(3):210\u2013219","journal-title":"Genet Med"},{"issue":"1","key":"763_CR8","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","volume":"122","author":"YH Chien","year":"2008","unstructured":"Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, Chen CA, Wu MH et al (2008) Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics 122(1):e39\u2013e45","journal-title":"Pediatrics"},{"issue":"6","key":"763_CR9","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","volume":"124","author":"YH Chien","year":"2009","unstructured":"Chien YH, Lee NC, Thurberg BL, Chiang SC, Zhang XK, Keutzer J, Huang AC, Wu MH et al (2009) Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics 124(6):e1116\u2013e1125","journal-title":"Pediatrics"},{"key":"763_CR10","doi-asserted-by":"crossref","unstructured":"Chien YH, Lee NC, Chen CA, Tsai FJ, Tsai WH, Shieh JY, Huang HJ, Hsu WC, Tsai TH, Hwu WL (2015) Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth. J Pediatr 166 (4):985-991 e981-982. doi:10.1016\/j.jpeds.2014.10.068","DOI":"10.1016\/j.jpeds.2014.10.068"},{"issue":"3","key":"763_CR11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","volume":"35","author":"CM Gelder van","year":"2012","unstructured":"van Gelder CM, van Capelle CI, Ebbink BJ, Moor-van Nugteren I, van den Hout JM, Hakkesteegt MM, van Doorn PA, de Coo IF et al (2012) Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy. J Inherit Metab Dis 35(3):505\u2013511","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"763_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-016-0446-7","volume":"11","author":"SS Peng","year":"2016","unstructured":"Peng SS, Hwu WL, Lee NC, Tsai FJ, Tsai WH, Chien YH (2016) Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study. Orphanet J Rare Dis 11(1):63","journal-title":"Orphanet J Rare Dis"},{"issue":"13","key":"763_CR13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0000000000002523","volume":"86","author":"BJ Ebbink","year":"2016","unstructured":"Ebbink BJ, Poelman E, Plug I, Lequin MH, van Doorn PA, Aarsen FK, van der Ploeg AT, van den Hout JM (2016) Cognitive decline in classic infantile Pompe disease: an underacknowledged challenge. Neurology 86(13):1260\u20131261","journal-title":"Neurology"},{"issue":"23","key":"763_CR14","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","volume":"106","author":"LR DeRuisseau","year":"2009","unstructured":"DeRuisseau LR, Fuller DD, Qiu K, DeRuisseau KC, Donnelly WH Jr, Mah C, Reier PJ, Byrne BJ (2009) Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A 106(23):9419\u20139424","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"763_CR15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mus.22202","volume":"44","author":"A Dubrovsky","year":"2011","unstructured":"Dubrovsky A, Corderi J, Lin M, Kishnani PS, Jones HN (2011) Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation. Muscle Nerve 44(6):897\u2013901","journal-title":"Muscle Nerve"},{"issue":"30","key":"763_CR16","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","volume":"273","author":"N Raben","year":"1998","unstructured":"Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L, LaMarca M, King C et al (1998) Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 273(30):19086\u201319092","journal-title":"J Biol Chem"},{"issue":"8","key":"763_CR17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","volume":"67","author":"RL Sidman","year":"2008","unstructured":"Sidman RL, Taksir T, Fidler J, Zhao M, Dodge JC, Passini MA, Raben N, Thurberg BL et al (2008) Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice. J Neuropathol Exp Neurol 67(8):803\u2013818","journal-title":"J Neuropathol Exp Neurol"},{"key":"763_CR18","doi-asserted-by":"crossref","first-page":"974819","DOI":"10.1155\/2013\/974819","volume":"2013","author":"A Iida","year":"2013","unstructured":"Iida A, Takino N, Miyauchi H, Shimazaki K, Muramatsu S (2013) Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice. Biomed Res Int 2013:974819","journal-title":"Biomed Res Int"},{"issue":"2","key":"763_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2011.02.006","volume":"103","author":"DD Koeberl","year":"2011","unstructured":"Koeberl DD, Luo X, Sun B, McVie-Wylie A, Dai J, Li S, Banugaria SG, Chen YT et al (2011) Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle. Mol Genet Metab 103(2):107\u2013112","journal-title":"Mol Genet Metab"},{"issue":"8","key":"763_CR20","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.4049\/jimmunol.1303326","volume":"193","author":"MS Joly","year":"2014","unstructured":"Joly MS, Martin RP, Mitra-Kaushik S, Phillips L, D'Angona A, Richards SM, Joseph AM (2014) Transient low-dose methotrexate generates B regulatory cells that mediate antigen-specific tolerance to alglucosidase alfa. J Immunol 193(8):3947\u20133958","journal-title":"J Immunol"},{"issue":"7","key":"763_CR21","doi-asserted-by":"crossref","first-page":"e40776","DOI":"10.1371\/journal.pone.0040776","volume":"7","author":"R Khanna","year":"2012","unstructured":"Khanna R, Flanagan JJ, Feng J, Soska R, Frascella M, Pellegrino LJ, Lun Y, Guillen D et al (2012) The pharmacological chaperone AT2220 increases recombinant human acid alpha-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease. PLoS One 7(7):e40776","journal-title":"PLoS One"},{"issue":"4\u20135","key":"763_CR22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0960-8966(99)00117-0","volume":"10","author":"N Raben","year":"2000","unstructured":"Raben N, Nagaraju K, Lee E, Plotz P (2000) Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene. Neuromuscul Disord 10(4\u20135):283\u2013291","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"763_CR23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1369\/jhc.7A7239.2007","volume":"55","author":"TV Taksir","year":"2007","unstructured":"Taksir TV, Griffiths D, Johnson J, Ryan S, Shihabuddin LS, Thurberg BL (2007) Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model. J Histochem Cytochem 55(10):991\u2013998","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"763_CR24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","volume":"101","author":"T Kikuchi","year":"1998","unstructured":"Kikuchi T, Yang HW, Pennybacker M, Ichihara N, Mizutani M, Van Hove JL, Chen YT (1998) Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest 101(4):827\u2013833","journal-title":"J Clin Invest"},{"issue":"3","key":"763_CR25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddu476","volume":"24","author":"DJ Falk","year":"2015","unstructured":"Falk DJ, Todd AG, Lee S, Soustek MS, ElMallah MK, Fuller DD, Notterpek L, Byrne BJ (2015) Peripheral nerve and neuromuscular junction pathology in Pompe disease. Hum Mol Genet 24(3):625\u2013636","journal-title":"Hum Mol Genet"},{"issue":"13","key":"763_CR26","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1523\/JNEUROSCI.4311-13.2014","volume":"34","author":"SE Wahl","year":"2014","unstructured":"Wahl SE, McLane LE, Bercury KK, Macklin WB, Wood TL (2014) Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci 34(13):4453\u20134465","journal-title":"J Neurosci"},{"issue":"1","key":"763_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1385-299X(97)00034-2","volume":"2","author":"G Rozas","year":"1997","unstructured":"Rozas G, Guerra MJ, Labandeira-Garcia JL (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brain Res Protoc 2(1):75\u201384","journal-title":"Brain Res Brain Res Protoc"},{"key":"763_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2012.12.005","volume":"52","author":"NC Lee","year":"2013","unstructured":"Lee NC, Shieh YD, Chien YH, Tzen KY, Yu IS, Chen PW, Hu MH, Hu MK et al (2013) Regulation of the dopaminergic system in a murine model of aromatic L-amino acid decarboxylase deficiency. Neurobiol Dis 52:177\u2013190","journal-title":"Neurobiol Dis"},{"key":"763_CR29","doi-asserted-by":"crossref","unstructured":"Deacon RM (2013) Measuring the strength of mice. J Vis Exp (76)","DOI":"10.3791\/2610"},{"issue":"2","key":"763_CR30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/hgtb.2012.009","volume":"23","author":"MK ElMallah","year":"2012","unstructured":"ElMallah MK, Falk DJ, Lane MA, Conlon TJ, Lee KZ, Shafi NI, Reier PJ, Byrne BJ et al (2012) Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9. Hum Gene Ther Methods 23(2):148\u2013156","journal-title":"Hum Gene Ther Methods"},{"key":"763_CR31","first-page":"31","volume":"2","author":"KZ Lee","year":"2011","unstructured":"Lee KZ, Qiu K, Sandhu MS, Elmallah MK, Falk DJ, Lane MA, Reier PJ, Byrne BJ et al (2011) Hypoglossal neuropathology and respiratory activity in pompe mice. Front Physiol 2:31","journal-title":"Front Physiol"},{"issue":"5","key":"763_CR32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s11940-013-0256-3","volume":"15","author":"EF Augustine","year":"2013","unstructured":"Augustine EF, Mink JW (2013) Enzyme replacement in neuronal storage disorders in the pediatric population. Curr Treat Options Neurol 15(5):634\u2013651","journal-title":"Curr Treat Options Neurol"},{"key":"763_CR33","doi-asserted-by":"crossref","unstructured":"Deacon RM (2013) Measuring motor coordination in mice. J Vis Exp (75):e2609","DOI":"10.3791\/2609"},{"issue":"3","key":"763_CR34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"NW Dunham","year":"1957","unstructured":"Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 46(3):208\u2013209","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"issue":"6207","key":"763_CR35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1126\/science.1254960","volume":"346","author":"IA McKenzie","year":"2014","unstructured":"McKenzie IA, Ohayon D, Li H, de Faria JP, Emery B, Tohyama K, Richardson WD (2014) Motor skill learning requires active central myelination. Science 346(6207):318\u2013322","journal-title":"Science"},{"issue":"3","key":"763_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00687878","volume":"23","author":"JJ Martin","year":"1973","unstructured":"Martin JJ, de Barsy T, van Hoof F, Palladini G (1973) Pompe\u2019s disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol 23(3):229\u2013244","journal-title":"Acta Neuropathol"},{"issue":"Pt 3","key":"763_CR37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","volume":"275","author":"JE Burda","year":"2016","unstructured":"Burda JE, Bernstein AM, Sofroniew MV (2016) Astrocyte roles in traumatic brain injury. Exp Neurol 275(Pt 3):305\u2013315","journal-title":"Exp Neurol"},{"issue":"37","key":"763_CR38","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","volume":"36","author":"ME Bosch","year":"2016","unstructured":"Bosch ME, Aldrich A, Fallet R, Odvody J, Burkovetskaya M, Schuberth K, Fitzgerald JA, Foust KD et al (2016) Self-complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid Lipofuscinosis (CLN3). J Neurosci 36(37):9669\u20139682","journal-title":"J Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0763-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T09:09:34Z","timestamp":1526029774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0763-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0763-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]}}}